Document and Entity Information
Document and Entity Information | May 12, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 12, 2022 |
Entity Registrant Name | DICE THERAPEUTICS, INC. |
Entity Central Index Key | 0001645569 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity File Number | 001-40794 |
Entity Incorporation State Country Code | DE |
Entity Tax Identification Number | 47-2286244 |
Entity Address, Address Line One | 400 East Jamie Court |
Entity Address, Address Line Two | Suite 300 |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 566-1420 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.0001 Par Value Per Share |
Trading Symbol | DICE |
Security Exchange Name | NASDAQ |